Suppr超能文献

新的含硫N-亚硝基氨基酸N-亚硝基噻唑烷-4-羧酸及其2-甲基衍生物在人尿中的出现及其形成。

Occurrence in human urine of new sulphur-containing N-nitrosamino acids N-nitrosothiazolidine 4-carboxylic acid and its 2-methyl derivative, and their formation.

作者信息

Ohshima H, O'Neill I K, Friesen M, Béréziat J C, Bartsch H

出版信息

J Cancer Res Clin Oncol. 1984;108(1):121-8. doi: 10.1007/BF00390983.

Abstract

To quantitate endogenous nitrosation reactions in man, the quantity of N-nitrosoproline (NPRO) excreted in the urine after ingestion of proline and/or nitrate was estimated. When this monitoring method (NPRO test) was applied in clinical and field studies, several hitherto unidentified N-nitroso compounds were frequently detected. These were recently identified as sulphur-containing N-nitrosamino acids, N-nitrosothiazolidine 4-carboxylic acid (NTCA), and trans- and cis-isomers of N-nitroso-2-methylthiazolidine 4-carboxylic acid (NMTCA). NTCA and NMTCA were readily formed in vitro following nitrosation at acidic pH of the respective precursor, thiazolidine 4-carboxylic acid (TCA) or of 2-methylthiazolidine 4-carboxylic acid (MTCA). As the latter compounds can be formed by reaction of L-cysteine with formaldehyde or acetaldehyde, respectively, NTCA and NMTCA were also formed by reacting L-cysteine with the respective aldehyde and with nitrite at optimal pH (2.5 for NTCA and 4.5 for NMTCA). Up to 95% of NTCA and NMTCA given orally to fasted rats was recovered as such in urine and faeces within 2 days. Administration of TCA or MTCA, together with nitrite increased the urinary excretion of NTCA and NMTCA, as did co-administration of L-cysteine, nitrite, and the respective aldehyde. NTCA and NMTCA were also detected in the 24-h urine of human volunteers, and smokers tended to excrete higher levels than nonsmokers. Daily excretion levels varied, however, and a diet supplemented with ascorbic acid significantly decreased the total amount of nitrosamino acids. NTCA and NMTCA may occur in human urine as a result of (i) intake of preformed N-nitroso compounds; (ii) intake of thiazolidine 4-carboxylic acid or its 2-methyl derivative and subsequent nitrosation in vivo; (iii) endogenous two-step synthesis by the reaction of L-cysteine with the respective aldehyde and a nitrosating agent. Thus, measurement of NTCA and NMTCA together with NPRO in urine may provide an index for the exposure of human subjects to nitrosamines or their precursors, i.e., nitrosating agents, certain aldehydes, or aldehyde-generating compounds. Our data demonstrate unequivocally that N-nitroso compounds are formed in the human body, as suggested previously by Druckrey. Their relevance to human cancer at specific sites should now be investigated.

摘要

为了定量人体中的内源性亚硝化反应,对摄入脯氨酸和/或硝酸盐后尿液中排泄的N-亚硝基脯氨酸(NPRO)的量进行了估算。当这种监测方法(NPRO测试)应用于临床和现场研究时,经常检测到几种迄今未被识别的N-亚硝基化合物。这些化合物最近被鉴定为含硫的N-亚硝基氨基酸、N-亚硝基噻唑烷-4-羧酸(NTCA)以及N-亚硝基-2-甲基噻唑烷-4-羧酸(NMTCA)的反式和顺式异构体。在各自的前体噻唑烷-4-羧酸(TCA)或2-甲基噻唑烷-4-羧酸(MTCA)在酸性pH下发生亚硝化反应后,NTCA和NMTCA很容易在体外形成。由于后一种化合物可分别由L-半胱氨酸与甲醛或乙醛反应形成,因此NTCA和NMTCA也可通过使L-半胱氨酸与相应的醛以及亚硝酸盐在最佳pH值(NTCA为2.5,NMTCA为4.5)下反应而形成。口服给予禁食大鼠的NTCA和NMTCA中,高达95%在2天内以原形在尿液和粪便中回收。给予TCA或MTCA以及亚硝酸盐会增加NTCA和NMTCA的尿排泄量,L-半胱氨酸、亚硝酸盐和相应醛共同给药时也是如此。在人类志愿者的24小时尿液中也检测到了NTCA和NMTCA,吸烟者的排泄水平往往高于不吸烟者。然而,每日排泄水平各不相同,补充抗坏血酸的饮食可显著降低亚硝基氨基酸的总量。NTCA和NMTCA可能在人类尿液中出现的原因有:(i)摄入预先形成的N-亚硝基化合物;(ii)摄入噻唑烷-4-羧酸或其2-甲基衍生物并随后在体内发生亚硝化反应;(iii)通过L-半胱氨酸与相应醛和亚硝化剂的反应进行内源性两步合成。因此,同时测量尿液中的NTCA、NMTCA和NPRO可能为人类受试者接触亚硝胺或其前体(即亚硝化剂、某些醛或醛生成化合物)提供一个指标。我们的数据明确证明,如Druckrey之前所暗示的,人体中会形成N-亚硝基化合物。现在应该研究它们与特定部位人类癌症的相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验